At the end of last week, Lundbased medtech company Clinical Laserthermia Systems, CLS, published its report for the third quarter 2021. The company’s CEO Dan Mogren came to BioStock’s studio to tell us more about the most important events of the past quarter and what lies ahead for CLS.
See the full interview with CLS CEO Dan Mogren below.
The content of BioStock’s news and analyses is independent but the work of BioStock is to a certain degree financed by life science companies. The above article concerns a company from which BioStock has received financing.